SCHEMBL30878362

SCHEMBL30878362

C#Cc1c(-c2ccccc2)c(=O)n(C)c2nc(Nc3ccc(N(C)CCN(C)C)cc3OC)ncc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.49
BTK Q06187 2/20 0.49
JAK3 P52333 1/20 0.46
FGFR1 P11362 1/20 0.44
PLK1 P53350 2/20 0.41
IGF1R P08069 2/20 0.40
MAPK7 Q13164 1/20 0.40
LRRK2 Q5S007 1/20 0.40
WEE1 P30291 2/20 0.39
FGFR4 P22455 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878436 0.90 EGFR (0.49) EGFRBTKJAK3FGFR1IGF1R
SCHEMBL30878727 0.89 EGFR (0.50) EGFRBTKJAK3FGFR1PLK1
SCHEMBL30878313 0.89 EGFR (0.49) EGFRBTKJAK3FGFR1PLK1
SCHEMBL30878484 0.84 EGFR (0.52) EGFRBTKJAK3PLK1MAPK7
SCHEMBL30878944 0.81 EGFR (0.56) EGFRBTKJAK3
SCHEMBL30878353 0.81 FGFR4 (0.47) EGFRBTKFGFR1WEE1FGFR4
SCHEMBL30879162 0.81 EGFR (0.48) EGFRBTKJAK3FGFR1IGF1R
SCHEMBL30879218 0.79 EGFR (0.49) EGFRBTKJAK3FGFR1PLK1
SCHEMBL30878454 0.76 FGFR1 (0.51) EGFRBTKJAK3FGFR1IGF1R
SCHEMBL30878385 0.76 CCNT1 (0.47) EGFRFGFR1WEE1FGFR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP claimed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO claimed
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed